Latest news
Loading news…
Iovance Biotherapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. New York, United States Founded 2007 501-1000 employees For Profit
Iovance Biotherapeutics is developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
543
Ticker
IOVA
NASDAQ
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- IOVA
- Exchange
- NASDAQ
- IPO date
- Aug 13, 2010
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 11
- Active products
- 18
- IT spend
- $6M
Company Info
- Founded
- 2007
- Employees
- 501-1000
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 835
- HQ
- New York, United States
- Region
- Greater New York Area, East Coast, Northeastern US
- Exit date
- Aug 13, 2010
Signals & Scores
- Heat score
- Medium
- Growth score
- High
- Trend (7d)
- -0.4
- Trend (30d)
- 1.5
- Trend (90d)
- 6
- Last leadership hire
- Jun 30, 2026
- Last layoff mention
- Aug 7, 2025
Acquisitions by Iovance Biotherapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Iovance Biotherapeutics
Vice President, Market Access & Policy, Cell Therapy
SVP Technical Operations
Chief Medical Officer
Interim CEO and President
543
professional contacts at Iovance Biotherapeutics
Contact execs at Iovance Biotherapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Iovance Biotherapeutics
Loading news…
FAQs about Iovance Biotherapeutics
People who checked this page also checked these
Sectors Iovance Biotherapeutics invests & acquires in
Browse the full Acquirezy directory.